Promoting Asthma Management Guidelines With Technology-Based Intervention and Care Coordination in Clinics and Schools

Trial statusRecruiting
Trial phaseNot applicable
Trial typeInterventional
Biological sexAll
Age4-12
SponsorMontefiore Medical Center

About this trial

The overall goal of this research study is to evaluate a multi-level program called PRAGMATIC-S to improve the delivery of guideline-based asthma care through a unique partnership between clinical practices and schools. PRAGMATIC-S represents a novel approach that addresses multiple barriers to adherence by bridging primary care and schools, ensuring delivery of guideline-based asthma care to urban children across these settings thereby improving adherence to therapy and clinical outcomes.

Eligibility criteria

Qualifiers

Physician-diagnosed asthma documented in EHR

Persistent asthma, not on controller medications or uncontrolled asthma despite therapy (with any one of the following per age-specific guidelines: in past month, >2 days/week with symptoms, >2 days/week using rescue medication, >2 days/month with nighttime symptoms, or >2 episodes/year that required systemic corticosteroids

Age 4 to 12 years, inclusive, attending pre-kindergarten through 7th grade in public / charter / private schools in New York City (the Bronx primarily) and also schools in lower Hudson Valley (Eastchester, Westchester, Rockland, Yonkers)

Caregiver is able to speak and understand either English or Spanish. Participants unable to read will be eligible as all surveys will be administered verbally by research personnel

Disqualifiers

Family plans to leave school or city within 6 months

Significant medical conditions (e.g., congenital heart disease, cystic fibrosis, or other chronic lung disease)

Children in foster care or other situations in which consent cannot be obtained from a legal guardian

Participation in concurrent asthma intervention study

Trial design

Treatments tested in this trial

  • PRAGMATIC-S

Treatment groups

420 Participants
are divided into 2 treatment groups

Sponsors and collaborators

Montefiore Medical Center

Lead sponsor

National Heart, Lung, and Blood Institute (NHLBI)

Collaborator